Methylphenidate Exposure Induces Dopamine Neuron Loss in Mice
plosone.org
plosone.org
Typical doses of Ritalin in kids (6+ years old) is 5-10 mg per day in two doses.[1] 6 year old weigh about 20 kg (50th percentile) so each dose is ~0.25 mg/kg (5/20). Even if you double the dose, it's 0.50 mg/kg, below the 1 mg/kg where the study saw no neuron loss.
To get to 10 mg/kg, kids would have to take 200 mg in a single dose. I'm pretty sure the side effects would be utterly intolerable even at half of that dose.
It's probably worth following up, but I wouldn't be worried about this finding.
[1] http://www.mayoclinic.org/drugs-supplements/methylphenidate-...
HED (mg/kg) = Animal Dose (mg/kg) x [Animal Km / Human Km]
We use 3 for mice and 25 for human (child)
HED = 10 x ( 3 / 25) = 1,2 mg/kg
In a 20kg kid we have a dose of 24 mg, which is only slightly higher than a normal dose.
My only reply is that the BSA method of dose conversation has issues of it's own (referred to in your paper) with regards to drug metabolism.
Also, the focus of the paper is on dose translations from animal to human studies. One would obviously want to be conservative in that regard.
I have a child (24kg) with - properly diagnosed - severe ADHD on 20mg daily and the benefits clearly outweigh the potential risks; as with everything in life, nothing has zero risk.
Because you build up a tolerance over time, which requires larger doses, and because untreated ADD/ADHD is also linked to increased creativity and some degree of impulsiveness (which can be a good thing, vs. indecisiveness).
If I were doing more creative work, I would probably go without during creative phases and with while producing (for example, as a journalist, go without to come up with ideas for stories, then back on to burn through the associated research, production, refining, etc.).
At higher doses, I'm able to fixate on one task to the exclusion of all else (e.g. distractions, music, hunger, illness); at moderate doses, I tend to flit between interesting topics until I find something I can easily focus on (or perhaps until the medication kicks in at full strength).
Withdrawing every weekend was uncomfortable, but better than psychosis.
ADD is part of who I am its just not very compatible with current work environments. I don't like to feel drugged all the time and I know that i'm ok with out being medicated.
I have developed sufficient coping skills as an adult to enable me to choose when I need to be medicated and when I don't.
And that's ignoring individual variation in response.
It shouldn't surprise anyone that so many drugs in development fail.
Could the drug "stunt" neurological development over the extent of a childhood? Even in low dosages?
I wish we wouldn't medicate so much, especially in young children!
Its easy to read articles/papers like the OP link and be alarmed, but the three biggest risk factors with Ritalin (and similar drugs) is that the dose is appropriate for weight, the dosage is scheduled properly and sleep.
If the dosage schedule is above the half life of the medication, and blood level is still high at +12 hours later then neurons will get "burned" and lost.
Don't sleep for the required hours and schedule, neurons get "burned" as well.
This is also why recreational crystal meth [1] is very bad for the brain. Crystal meth overloads the neurons and definitely not equivalent to Rx Ritalin as intelligently prescribed.
[1] http://www.drugabuse.gov/publications/drugfacts/methamphetam...
"Crystal meth" isn't equivalent to Ritalin (methylphenidate), but it is equivalent to Desoxyn (brand name for methamphetamine), and more or less equivalent to Adderall (d-amphetamine, with a bit of l-amphetamine).
All three drugs are prescribed for a variety of conditions and, in appropriate doses, are safe[0]. The main difference between Desoxyn and Adderall is that the extra methyl group attached to the amphetamine makes it cross the blood-brain barrier more easily, which means that the equivalent doses are smaller (by weight). The metabolic processes and the effects on the brain are virtually identical, though, so it's misleading to draw a line between them and label one as "good" and the other "bad".
The real reason that people think of crystal meth as "bad" is because it's taken in far higher doses recreationally than would ever be prescribed medically, and because it's smoked (not that this is inherently bad, but changing the means of ingestion changes the onset, duration of effects, etc.[1])
[0] At least, to the extent that we can say that any pharmaceutical is "safe"
[1] This is why nicotine gum is frustrating to many smokers, because it takes much longer to absorb.
I'm absolutely sure. My son takes methylphenidate for traumatic narcolepsy and hyperphagia. At ~60 kg with a 30mg dose, he's got tremors, sweats, chattering teeth, etc.
I can only assume that the researchers have reason to study using these higher doses in mice, but 1mg/kg and 10mg/kg was the first thing that caught my eye. Neurological degeneration seems entirely plausible when you're frying a brain with speed (so to speak).
"Collectively, our results suggest that chronic MPH usage in mice at doses spanning the therapeutic range in humans, especially at prolonged higher doses, has long-term neurodegenerative consequences."
* Stunted height - I'm several inches shorter than my father, grandfathers and uncles (all in the 6'2" to 6'4" range).
* Very short temper and aggressive tendencies (went away entirely in my teens when I was on significantly lower doses)
I also remember having serious withdrawal symptoms if I missed doses.
These results can only be interpreted in the context on normal brain structure and function, and thus would have direct implications for the illicit/neurocognitive use of MPH. Since the underlying anatomy and biochemistry of ADHD has not been definitively characterized, our findings may or may not be generalizable to the vast majority of humans who are properly diagnosed with ADHD and are prescribed methylphenidate. Nevertheless, this work supports studies [51], [57], [58], [59] that demonstrate that drugs shown to increase the levels of dopamine in the synaptic cleft can contribute to degenerative changes in the basal ganglia.
That's an understatement. The same could be said of any "disorder" or "syndrome" the study of which is motivated primarily by commerce in pharmaceuticals. If humanity survives long enough, future medicine will see "ADHD" as lying mostly within normal human psychological variety. Our clumsy efforts at treatment will be seen as prescribing 6" shoe risers to everyone, whether they're 5'1" or 6'3".
In order to derive clinical recommendations (like "stop taking ritalin") the potential damage has to be higher than that of all the "side effects" of ADHD, for example violence, depression and social problems. Which currently does not seem to be the case...
Symptoms of pre-Parkinsonian dopaminergic neuron loss are (anhedonia, depression, psychiatric weirdness without movement disorder) are just beginning to be described, and it's very likely that stimulant use will be shown to cause pre-Parkinsonian symptoms in human populations once we know what to look for, and after somebody decides to spend tons of time and money investigating it.
Maybe the appropriate clinical recommendation is to exercise caution with DAT ligands, and to use them as minimally as possible?
At the low dose, the mice showed no significant loss but were vulnerable to a sub-threshold dose of a toxin and toxin+MPH mice showed a ~20% loss.
This is in figure 1, and in the discussion. Exactly what behavioral effects result from a 20% loss of DA neurons is still an open question.
So, the clinical implication is that people on methylphenidate might be vulnerable to things (rotenone, heavy metals, etc) which aren't toxic to "normal" people.
It's not like it would be an immediate side effect.
Often brain damage chronically over time is not immediately visible.
It's not like this drug is prescribed rarely or introduced very recently...
"Both the accumulation of DOPAL and the enhancement of rotenone-induced toxicity were abrogated by inhibiting the formation of DOPAL with the MAO inhibitor, clorgyline. These observations suggest that the MAO-catalyzed formation of DOPAL and its accumulation by various mechanisms may be important processes that aggravate the neurotoxicity associated with mitochondrial dysfunction."
http://pharmrev.aspetjournals.org/content/59/2/125.full
So this is why MAO inhibitors are neuroprotective. They prevent this reaction.
I was using modafinil before with some success. The only problem was that my sleep patterns were all over the map and getting regular good sleep was becoming difficult.
As for the sleep patterns, I've found sporadic use of melatonin to be quite helpful:
http://www.longecity.org/forum/topic/61161-methylphenidate-n...
http://www.reddit.com/r/Nootropics/comments/1yd5bf/methylphe...
http://www.plosone.org/annotation/listThread.action?root=539...
https://www.quora.com/What-are-the-long-term-effects-of-Adde...
---
And some studies suggesting other adverse neurodegenerative effects of MPH as well:
"Methylphenidate treatment induces oxidative stress in young rat brain"
http://www.sciencedirect.com/science/article/pii/S0006899306...
"Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats."